-
-
-
-
-
-
-
Maxim Group Starts Evaxion Biotech (EVAX) at Buy
-
-
-
-
-
-
-
Sidoti Events, LLC's Year-End Virtual Investor Conference
-
-
-
-
-
-
-
Jones Trading Starts Evaxion Biotech (EVAX) at Buy
-
-
-
-
-
-
-
Evaxion Biotech (EVAX) receives grant funding to design new polio vaccine
-
-
-
-
-
-
-
Evaxion Biotech (EVAX) announces pricing of $10.8 million public offering
-
-
-
-
-
-
-
Evaxion Biotech (EVAX) Misses Q3 EPS by 4c
-
-
-
-
-
-
-
Evaxion Biotech (EVAX) reports convincing one-year data from phase 2 trial of EVX-01
-
415,287 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

